Roles of Notch Signaling in the Tumor Microenvironment

Roles of Notch Signaling in the Tumor Microenvironment

The Notch signaling pathway is an architecturally simple signaling mechanism, well known for its role in cell fate regulation during organ development and in tissue homeostasis. In keeping with its importance for normal development, dysregulation of Notch signaling is increasingly associated with di...

Full description

Bibliographic Details
Main Authors:	Antonino B. D’Assoro, Roberto Leon-Ferre, Eike-Benjamin Braune, Urban Lendahl
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	International Journal of Molecular Sciences
Subjects:	Notch signaling cancer tumor tumor microenvironment oncogene tumor suppressor gene
Online Access:	https://www.mdpi.com/1422-0067/23/11/6241

Similar Items

Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma
by: Elena Parmigiani, et al.
Published: (2020-10-01)

The Challenge of Targeting Notch in Hematologic Malignancies
by: Fiorela N Hernandez Tejada, et al.
Published: (2014-06-01)

From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
by: Chiara Bazzichetto, et al.
Published: (2020-01-01)

Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment
by: Kai Huang, et al.
Published: (2023-01-01)

Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
by: Nadezda Zhdanovskaya, et al.
Published: (2021-10-01)

Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
by: Elizabeth A. Comen, et al.
Published: (2018-06-01)

Metabolite-derived protein modifications modulating oncogenic signaling
by: Yawen Liu, et al.
Published: (2022-09-01)

Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy
by: Man Wang, et al.
Published: (2024-02-01)

Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
by: Barbara Seliger, et al.
Published: (2022-05-01)

Genetic Inactivation of <i>Notch1</i> Synergizes with Loss of <i>Trp53</i> to Induce Tumor Formation in the Adult Mouse Forebrain
by: Elena Parmigiani, et al.
Published: (2022-11-01)

Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
by: Bikesh K. Nirala, et al.
Published: (2023-07-01)

The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer
by: Shashank Kumar, et al.
Published: (2022-09-01)

Editorial: Recent advances in diagnosis, prognosis, and therapy of oncogenic virus-driven tumors
by: Mauro Tognon, et al.
Published: (2024-04-01)

Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers
by: He Fang, et al.
Published: (2022-10-01)

LncRNA profiles from Notch signaling: Implications for clinical management and tumor microenvironment of colorectal cancer
by: Qin Dang, et al.
Published: (2022-07-01)

Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective
by: Abdellah Akil, et al.
Published: (2021-02-01)

Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
by: Julia O. Misiorek, et al.
Published: (2021-01-01)

WNT5A in tumor development and progression: A comprehensive review
by: Maura Lima Pereira Bueno, et al.
Published: (2022-11-01)

Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destruction
by: Hayley M. Sabol, et al.
Published: (2022-06-01)

Notch Signaling in Neuroendocrine Tumors
by: Judy Sue Crabtree, et al.
Published: (2016-04-01)

Suggested roles for microRNA in tumors
by: Perge Pál, et al.
Published: (2015-04-01)

New Insight into microRNA Functions in Cancer: Oncogene–microRNA–Tumor Suppressor Gene Network
by: Kecheng Zhou, et al.
Published: (2017-07-01)

Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
by: Luiz Paulo Chaves, et al.
Published: (2021-11-01)

The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC
by: Xiaohua Li, et al.
Published: (2021-07-01)

Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients
by: Hiroki Sasamori, et al.
Published: (2022-05-01)

The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
by: Vivek Kumar, et al.
Published: (2021-04-01)

The role of Hedgehog and Notch signaling pathway in cancer
by: Ruolan Xia, et al.
Published: (2022-12-01)

Notching on cancer’s door: Notch signaling in brain tumors
by: Marcin eTeodorczyk, et al.
Published: (2015-01-01)

Tumor Microenvironment
by: Borros Arneth
Published: (2019-12-01)

Identification of a Notch transcriptomic signature for breast cancer
by: Eike-Benjamin Braune, et al.
Published: (2024-01-01)

Notch-Signaling Deregulation Induces Myeloid-Derived Suppressor Cells in T-Cell Acute Lymphoblastic Leukemia
by: Paola Grazioli, et al.
Published: (2022-04-01)

Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer
by: Soha Mcheik, et al.
Published: (2020-12-01)

The quest for targets executing MYC-dependent cell transformation
by: Markus eHartl
Published: (2016-06-01)

BARD1 mystery: tumor suppressors are cancer susceptibility genes
by: Yousef M. Hawsawi, et al.
Published: (2022-06-01)

Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
by: Roopak Murali, et al.
Published: (2023-04-01)

A Review on the Molecular Pathology of Epithelial Thyroid Tumors
by: Seyedeh Adeleh Razavi, et al.
Published: (2018-10-01)

Immunotherapy of targeting MDSCs in tumor microenvironment
by: Hongshu Sui, et al.
Published: (2022-09-01)

Tumor suppressor and oncogenic role of long non-coding RNAs in cancer
by: Esra Guzel, et al.
Published: (2020-02-01)

The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?
by: Lin Zhang, et al.
Published: (2020-09-01)

Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis
by: Antonino Bruno, et al.
Published: (2022-08-01)